Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2016 Filed Dec 20, 2019 16:35 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,789 | $6.03 Strike: $6.03 | $34,907.67 |
DisclosureSEC source: 0001096906-19-000434 · primary_doc.xml · derivative · entry 5 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Class A Common Stock · 5,789 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Dec 26, 2019 17:53 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,789 | $6.03 Strike: $6.03 | $34,907.67 |
DisclosureSEC source: 0001096906-19-000438 · primary_doc.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Class A Common Stock · 5,789 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Jan 6, 2020 23:27 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 92,610 | $6.62 Strike: $6.62 | $613,078.20 |
DisclosureSEC source: 0001096906-20-000004 · primary_doc.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,610 Underlying: Class C Common Stock · 92,610 shares Expires 2021-12-02 F6 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Jan 6, 2020 22:47 UTC |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 92,610 | $6.62 Strike: $6.62 | $613,078.20 |
DisclosureSEC source: 0001096906-20-000003 · primary_doc.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,610 Underlying: Class C Common Stock · 92,610 shares Expires 2021-12-02 F6 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F6 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Jan 6, 2020 18:38 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,789 | $6.03 Strike: $6.03 | $34,907.67 |
DisclosureSEC source: 0001096906-20-000002 · primary_doc.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Class A Common Stock · 5,789 shares Expires 2026-12-02 F13 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F13 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F13 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F13 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F13 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Jan 10, 2020 18:47 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,789 | $6.03 Strike: $6.03 | $34,907.67 |
DisclosureSEC source: 0001096906-20-000009 · primary_doc.xml · derivative · entry 4 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Class A Common Stock · 5,789 shares Expires 2026-12-02 F3 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Jan 15, 2020 20:19 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,153 | $6.03 Strike: $6.03 | $139,612.59 |
DisclosureSEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 10 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,153 Underlying: Class A Common Stock · 23,153 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 02, 2016 Filed Feb 12, 2020 16:40 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001096906-20-000067 · primary_doc.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F9 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Feb 12, 2020 18:18 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001096906-20-000072 · primary_doc.xml · derivative · entry 7 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Feb 12, 2020 20:23 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001096906-20-000075 · primary_doc.xml · derivative · entry 12 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F12 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F12 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F12 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F12 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F12 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Feb 12, 2020 17:33 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001096906-20-000068 · primary_doc.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 1, 2020 21:41 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000523 · primary_doc.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F11 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 7, 2020 22:53 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000573 · form4.xml · derivative · entry 7 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 8, 2020 17:03 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000586 · form4.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F11 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 8, 2020 15:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000584 · form4.xml · derivative · entry 8 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 8, 2020 14:21 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000582 · form4.xml · derivative · entry 4 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed May 8, 2020 14:15 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000580 · form4.xml · derivative · entry 13 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F13 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 3, 2020 22:58 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000811 · form4.xml · derivative · entry 11 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F11 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 3, 2020 22:22 UTC Amendment |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000809 · form4.xml · derivative · entry 13 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F13 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F13 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 3, 2020 21:39 UTC Amendment |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000805 · form4.xml · derivative · entry 7 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 3, 2020 22:09 UTC Amendment |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000807 · form4.xml · derivative · entry 8 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 4, 2020 14:39 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000813 · form4.xml · derivative · entry 4 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 9, 2020 21:22 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000833 · primary_doc.xml · derivative · entry 7 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 9, 2020 19:27 UTC Amendment |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,155 | $5.73 Strike: $5.73 | $69,648.15 |
DisclosureSEC source: 0001445866-20-000830 · primary_doc.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,155 Underlying: Class A Common Stock · 12,155 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 9, 2020 17:57 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,155 | $5.73 Strike: $5.73 | $69,648.15 |
DisclosureSEC source: 0001445866-20-000828 · form4.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,155 Underlying: Class A Common Stock · 12,155 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 10, 2020 16:07 UTC |
Johnson Stephen CharlesVP - Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,079 | $5.73 Strike: $5.73 | $34,832.67 |
DisclosureSEC source: 0001445866-20-000834 · primary_doc.xml · derivative · entry 7 Johnson Stephen Charles · CIK 0001661597 · VP - Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,079 Underlying: Class A Common Stock · 6,079 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 11, 2020 19:21 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,311 | $5.73 Strike: $5.73 | $139,302.03 |
DisclosureSEC source: 0001445866-20-000838 · primary_doc.xml · derivative · entry 7 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,311 Underlying: Class A Common Stock · 24,311 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 11, 2020 22:31 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,078 | $5.73 Strike: $5.73 | $34,826.94 |
DisclosureSEC source: 0001445866-20-000840 · form4.xml · derivative · entry 13 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,078 Underlying: Class A Common Stock · 6,078 shares Expires 2026-12-02 F11 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F11 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 11, 2020 17:32 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 97,241 | $6.29 Strike: $6.29 | $611,645.89 |
DisclosureSEC source: 0001445866-20-000837 · primary_doc.xml · derivative · entry 3 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,241 Underlying: Class C Common Stock · 97,241 shares Expires 2021-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 12, 2020 20:05 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,311 | $5.73 Strike: $5.73 | $139,302.03 |
DisclosureSEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 4 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,311 Underlying: Class A Common Stock · 24,311 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jun 12, 2020 18:55 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,155 | $5.73 Strike: $5.73 | $69,648.15 |
DisclosureSEC source: 0001445866-20-000843 · primary_doc.xml · derivative · entry 4 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,155 Underlying: Class A Common Stock · 12,155 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F5 · shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F5 · price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. Read SEC document |
| December 02, 2016 Filed Jul 24, 2020 00:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001040 · primary_doc.xml · derivative · entry 12 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F12 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 23, 2020 22:58 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001039 · primary_doc.xml · derivative · entry 14 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F14 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 23, 2020 21:26 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001038 · primary_doc.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 23, 2020 20:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001037 · primary_doc.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F9 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 27, 2020 17:34 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001047 · form4.xml · derivative · entry 7 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 31, 2020 22:49 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,919 | $5.59 Strike: $5.59 | $139,297.21 |
DisclosureSEC source: 0001445866-20-001099 · primary_doc.xml · derivative · entry 7 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,919 Underlying: Class A Common Stock · 24,919 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 31, 2020 21:49 UTC |
Johnson Stephen CharlesVP - Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001096 · primary_doc.xml · derivative · entry 7 Johnson Stephen Charles · CIK 0001661597 · VP - Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 31, 2020 19:39 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001093 · primary_doc.xml · derivative · entry 7 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jul 31, 2020 18:25 UTC |
Sill Garrett S.CFO and Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,155 | $5.73 Strike: $5.73 | $69,648.15 |
DisclosureSEC source: 0001445866-20-001091 · primary_doc.xml · derivative · entry 10 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,155 shares Expires 2026-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Aug 3, 2020 21:29 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 99,672 | $6.14 Strike: $6.14 | $611,986.08 |
DisclosureSEC source: 0001445866-20-001100 · primary_doc.xml · derivative · entry 3 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,672 Underlying: Class C Common Stock · 99,672 shares Expires 2021-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Aug 6, 2020 22:33 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,919 | $5.59 Strike: $5.59 | $139,297.21 |
DisclosureSEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 4 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,919 Underlying: Class A Common Stock · 24,919 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Aug 18, 2020 19:34 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,459 | $5.59 Strike: $5.59 | $69,645.81 |
DisclosureSEC source: 0001445866-20-001226 · primary_doc.xml · derivative · entry 4 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,459 Underlying: Class A Common Stock · 12,459 shares Expires 2026-12-02 F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · price: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on December 2, 2016 as an option for 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Oct 8, 2020 22:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001445866-20-001512 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F8 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Dec 9, 2020 16:30 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001096906-20-000452 · form4.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Dec 19, 2020 00:22 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 99,672 | $6.14 Strike: $6.14 | $611,986.08 |
DisclosureSEC source: 0001096906-20-000523 · form4.xml · derivative · entry 3 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,672 Underlying: Class C Common Stock · 99,672 shares Expires 2021-12-02 F3 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F3 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F3 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F3 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F3 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Dec 18, 2020 23:05 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001096906-20-000518 · form4.xml · derivative · entry 15 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F13 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · price: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · balance_after: This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Dec 30, 2020 23:19 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,230 | $5.59 Strike: $5.59 | $34,825.70 |
DisclosureSEC source: 0001096906-20-000574 · form4.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,230 Underlying: Class A Common Stock · 6,230 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · price: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Dec 31, 2020 22:03 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 99,672 | $6.14 Strike: $6.14 | $611,986.08 |
DisclosureSEC source: 0001096906-20-000581 · form4.xml · derivative · entry 4 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,672 Underlying: Class C Common Stock · 99,672 shares Expires 2021-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · price: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option for either 80,000 shares of Class A Common Stock at an exercise price of $7.73 per share or 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock at an exercise price of $7.73 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| December 02, 2016 Filed Jan 7, 2021 16:20 UTC |
Overbaugh Jason G.Director · VP/Ntnl Mkting Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,919 | $5.59 Strike: $5.59 | $139,297.21 |
DisclosureSEC source: 0001096906-21-000039 · form4.xml · derivative · entry 4 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,919 Underlying: Class A Common Stock · 24,919 shares Expires 2026-12-02 F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.